Status:
COMPLETED
CROS Application in CI
Lead Sponsor:
University of Miami
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bilateral profound sensorineural hearing loss (PSNHL) is often treated with Cochlear Implants. The majority of bilaterally deafened patients, however, often only receive a unilateral cochlear implant ...
Eligibility Criteria
Inclusion
- Unilateral Advanced Bionics CI recipient
- ≥ 6 months CI-listening experience and/or better than 50%-word recognition on Consonant-Nucleus-Consonant (CNC) word testing
- English speaking
Exclusion
- Subjects who do not meet one or more of the above mentioned inclusion criteria are excluded from the study
Key Trial Info
Start Date :
August 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2021
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03243097
Start Date
August 24 2017
End Date
March 26 2021
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami Department of Otolaryngology
Miami, Florida, United States, 33136